SNY - IGM Biosciences to cut 22% of workforce shut down blood cancer programs
2023-12-05 16:42:48 ET
More on IGM Biosciences
- IGM Biosciences: What Causes The Very High Short Interest In This Ticker
- IGM Biosciences GAAP EPS of -$1.04 beats by $0.21, revenue of $0.51M misses by $0.34M
- IGM Biosciences Chief Commercial Officer discloses sale of 935 company shares
- Seeking Alpha’s Quant Rating on IGM Biosciences
- Historical earnings data for IGM Biosciences
For further details see:
IGM Biosciences to cut 22% of workforce, shut down blood cancer programs